世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031827

PoC(ポイントオブケア)血糖検査市場規模、シェア、動向分析、予測 2022 - 2030

Grand View Research Inc.

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis And Segment Forecasts, 2022 - 2030

発刊日 2022/04

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000031827

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ポイントオブケア血糖検査市場規模、シェア、動向分析レポート:製品別(Accu-Chek Inform II、Freestyle Lite)、地域別(北米、ヨーロッパ、APAC、中南米、中等・アフリカ)、およびセグメント予測、2022〜2030

レポートの概要

世界のポイントオブケア血糖検査の市場規模は2021年に31億ドルと評価され、2022年から2030年までは4.1%のCAGRで拡大すると予想されます。高齢者人口の増加、即時に結果が出る、したがって患者ケアの拡充につながる、といったポイントオブケア(POC)診断検査の能力、および電子カルテの市場浸透率の上昇、などが影響力の強い成長要因です。特に診断の分野で熟練したスタッフが不足していることも血糖POC診断製品の普及を促進すると予想されます。糖尿病の存在がCOVID-19による死亡リスクを高めるため、市場は勢いを増すでしょう。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Point-of-Care (POC) Glucose Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Introduction of CLIA waived tests
3.4.1.2. Growing prevalence of diabetes
3.4.1.3. Rising demand for short turnaround time glucose POC testing
3.4.2. Market restraint analysis
3.4.2.1. Potential interference and calibration issues in glucose meters
3.4.2.2. Presence of ambiguous regulatory as well as reimbursement framework
3.5. Point-of-Care(POC) Glucose Testing Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Point-of-Care (POC) Glucose Testing Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Accu-Check Aviva Meter
4.1.2. Onetouch Verio Flex
4.1.3. i-STAT
4.1.4. Freestyle Lite
4.1.5. Bayer CONTOUR Blood Glucose Monitoring System
4.1.6. True Metrix
4.1.7. Accu-Check Inform II
4.1.8. StatStrip
4.1.9. Others
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Point-of-Care (POC) Glucose Testing Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Accu-Check Aviva Meter
4.5.1.1. Accu-Check Aviva Meter market estimates and forecast, 2018 - 2030
4.5.2. Onetouch Verio Flex
4.5.2.1. Onetouch Verio Flex market estimates and forecast, 2018 - 2030
4.5.3. i-STAT
4.5.3.1. I-STAT market estimates and forecast, 2018 - 2030
4.5.4. Freestyle Lite
4.5.4.1. Freestyle Lite market estimates and forecast, 2018 - 2030
4.5.5. Bayer Contour Blood Glucose Monitoring System
4.5.5.1. Bayer Contour Blood Glucose Monitoring System market estimates and forecast, 2018 - 2030
4.5.6. True Metrix
4.5.6.1. TRUE METRIX market estimates and forecast, 2018 - 2030
4.5.7. Accu-Check Inform II
4.5.7.1. Accu-Check Inform II market estimates and forecast, 2018 - 2030
4.5.8. StatStrip
4.5.8.1. StatStrip market estimates and forecast, 2018 - 2030
4.5.9. Others
4.5.9.1. Others market estimates and forecast, 2018 - 2030

Chapter 5. Point-of-Care (POC) Glucose Testing Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2018 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2021
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2028:
5.7. North America
5.7.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.7.2. U.S.
5.7.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.7.3. Canada
5.7.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.8. Europe
5.8.1. U.K.
5.8.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.8.2. Germany
5.8.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.8.3. France
5.8.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.8.4. Italy
5.8.4.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.8.5. Spain
5.8.5.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.8.6. Russia
5.8.6.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.9. Asia Pacific
5.9.1. Japan
5.9.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.9.2. China
5.9.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.9.3. India
5.9.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.9.4. Australia
5.9.4.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.9.5. Thailand
5.9.5.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.9.6. South Korea
5.9.6.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.10. Latin America
5.10.1. Brazil
5.10.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.10.2. Mexico
5.10.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.10.3. Argentina
5.10.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.10.4. Colombia
5.10.4.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.11. MEA
5.11.1. Saudi Arabia
5.11.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.11.2. South Africa
5.11.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
5.11.3. UAE
5.11.3.1. Market estimates and forecast, 2018 - 2030 (USD million)

Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2021
6.3.4. F. Hoffmann-La Roche Ltd.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Abbott
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Nipro
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. PlatInium Equity Advisors, LLC (Lifescan, Inc.)
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Nova Biomedical
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. ACON Laboratories
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Trividia Health, Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Prodigy Diabetes Care, LLC
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Bayer AG/Ascensia Diabetes Care Holdings AG
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. EKF Diagnostics
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 3 North America Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 5 Canada Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 6 Europe Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 7 Europe Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 8 Germany Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 9 U.K. Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 10 France Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 11 Italy Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 12 Spain Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 13 Russia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 14 APAC Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 15 APAC Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 16 Japan Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 17 China Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 18 India Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 19 Australia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 20 Thailand Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 21 South Korea Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 22 Latin America Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 23 Latin America Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 24 Brazil Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 25 Mexico Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 26 Argentina Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 27 Colombia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 28 Middle East and Africa Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 30 South Africa Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 31 Saudi Arabia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 32 UAE Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Point-of-Care (POC) Glucose Testing market: market outlook
Fig. 14 Point-of-Care (POC) Glucose Testing market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Point-of-Care (POC) Glucose Testing market driver impact
Fig. 20 Point-of-Care (POC) Glucose Testing market restraint impact
Fig. 21 Point-of-Care (POC) Glucose Testing market strategic initiatives analysis
Fig. 22 Point-of-Care (POC) Glucose Testing market: product movement analysis
Fig. 23 Point-of-Care (POC) Glucose Testing market: product outlook and key takeaways
Fig. 24 Accu Check Aviva meter market estimates and forecast, 2018 - 2030
Fig. 25 Onetouch Verio Flex market estimates and forecast, 2018 - 2030
Fig. 26 i-STAT market estimates and forecast, 2018 - 2030
Fig. 27 Freestyle Lite market estimates and forecast, 2018 - 2030
Fig. 28 Bayer CONTOUR blood glucose monitoring system market estimates and forecast, 2018 - 2030
Fig. 29 True Metrix market estimates and forecast, 2018 - 2030
Fig. 30 Accu-Chek Inform II market estimates and forecast, 2018 - 2030
Fig. 31 StatStrip market estimates and forecast, 2018 - 2030
Fig. 32 Other market estimates and forecast, 2018 - 2030
Fig. 33 Global Point-of-Care (POC) Glucose Testing market: regional movement analysis
Fig. 34 Global Point-of-Care (POC) Glucose Testing market: regional outlook and key takeaways
Fig. 35 Global market shares and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America: SWOT
Fig. 42 Europe SWOT
Fig. 43 Asia Pacific SWOT
Fig. 44 Latin America SWOT
Fig. 45 MEA SWOT
Fig. 46 North America, by country
Fig. 47 North America
Fig. 48 North America market estimates and forecast, 2018 - 2030
Fig. 49 U.S.
Fig. 50 U.S. market estimates and forecast, 2018 - 2030
Fig. 51 Canada
Fig. 52 Canada market estimates and forecast, 2018 - 2030
Fig. 53 Europe
Fig. 54 Europe. market estimates and forecast, 2018 - 2030
Fig. 55 U.K.
Fig. 56 U.K. market estimates and forecast, 2018 - 2030
Fig. 57 Germany
Fig. 58 Germany market estimates and forecast, 2018 - 2030
Fig. 59 France
Fig. 60 France market estimates and forecast, 2018 - 2030
Fig. 61 Italy
Fig. 62 Italy market estimates and forecast, 2018 - 2030
Fig. 63 Spain
Fig. 64 Spain market estimates and forecast, 2018 - 2030
Fig. 65 Russia
Fig. 66 Russia market estimates and forecast, 2018 - 2030
Fig. 67 Asia Pacific
Fig. 68 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 69 Japan
Fig. 70 Japan market estimates and forecast, 2018 - 2030
Fig. 71 China
Fig. 72 China market estimates and forecast, 2018 - 2030
Fig. 73 India
Fig. 74 India market estimates and forecast, 2018 - 2030
Fig. 75 Australia
Fig. 76 Australia market estimates and forecast, 2018 - 2030
Fig. 77 Thailand
Fig. 78 Thailand market estimates and forecast, 2018 - 2030
Fig. 79 South Korea
Fig. 80 South Korea market estimates and forecast, 2018 - 2030
Fig. 81 Latin America
Fig. 82 Latin America market estimates and forecast, 2018 - 2030
Fig. 83 Brazil
Fig. 84 Brazil market estimates and forecast, 2018 - 2030
Fig. 85 Mexico
Fig. 86 Mexico market estimates and forecast, 2018 - 2030
Fig. 87 Argentina
Fig. 88 Argentina market estimates and forecast, 2018 - 2030
Fig. 89 Colombia
Fig. 90 Colombia market estimates and forecast, 2018 - 2030
Fig. 91 Middle East and Africa
Fig. 92 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 93 South Africa
Fig. 94 South Africa market estimates and forecast, 2018 - 2030
Fig. 95 Saudi Arabia
Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 97 UAE
Fig. 98 UAE market estimates and forecast, 2018 - 2030
Fig. 99 Participant categorization- Point-of-Care (POC) Glucose Testing market
Fig. 100 Market share of key market players- Point-of-Care (POC) Glucose Testing market

この商品のレポートナンバー

0000031827

TOP